Stocktoria
COLLEGIUM PHARMACEUTICAL, INC COLL
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-05-07
COLLEGIUM PHARMACEUTICAL, INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $780.6M | $631.4M | $566.8M | $463.9M | $276.9M |
| Gross profit | $463.3M | $377.3M | $326.2M | $209.5M | $150.6M |
| R&D expense | — | $0 | $0 | $4.0M | $9.5M |
| SG&A expense | $284.8M | $210.4M | $159.2M | $172.2M | $119.0M |
| Operating income | $179.6M | $169.9M | $167.0M | $33.3M | $17.6M |
| Interest expense | — | — | $83.3M | $63.2M | $21.0M |
| Income tax | $29.7M | $29.4M | $27.6M | -$3.8M | -$74.9M |
| Net income | $62.9M | $69.2M | $48.2M | -$25.0M | $71.5M |
| EPS (diluted) | $1.73 | $1.86 | $1.29 | $-0.74 | $1.86 |
| Operating cash flow | $329.3M | $205.0M | $274.7M | $124.2M | $103.6M |
| Free cash flow | $327.6M | $203.3M | $274.3M | $122.6M | $101.6M |
| Cash & equivalents | $231.3M | $70.6M | $238.9M | $173.7M | $186.4M |
| Inventory | $40.9M | $35.6M | $32.3M | $46.5M | $17.4M |
| Total assets | $1.7B | $1.7B | $1.1B | $1.2B | $692.1M |
| Total liabilities | $1.4B | $1.4B | $947.9M | $979.3M | $489.1M |
| Shareholders' equity | $301.7M | $228.8M | $195.4M | $194.8M | $202.9M |
Source: SEC EDGAR filings · CIK 0001267565 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.